ONWARD Field Clinical Specialist Markus Rieger will discuss the company's development of ARC Therapy -- Targeted, programmed stimulation of the spinal cord. Neurostimulation is viewed as an advancement with great promise for spinal cord injury recovery and ONWARD is committed to translating this therapy from research to clinical practice. Markus will be joined by Jane Symonds, Clinical Lead & Centre Manager at Neurokinex, who will share her clinic’s experience using transcutaneous spinal cord stimulation to improve functional recovery in people with SCI